139 related articles for article (PubMed ID: 37604499)
21. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
Zhan X; Li L; Wu M; Lang J
Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
[TBL] [Abstract][Full Text] [Related]
22. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma.
Cao SN; Chang KH; Luthra R; Liu J
Mod Pathol; 2003 Oct; 16(10):1048-52. PubMed ID: 14559989
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.
Yoneoka Y; Yoshida H; Ishikawa M; Shimizu H; Uehara T; Murakami T; Kato T
J Gynecol Oncol; 2019 Jan; 30(1):e7. PubMed ID: 30479091
[TBL] [Abstract][Full Text] [Related]
24. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
[TBL] [Abstract][Full Text] [Related]
25. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.
Hemminki K; Aaltonen L; Li X
Cancer; 2003 May; 97(10):2432-9. PubMed ID: 12733142
[TBL] [Abstract][Full Text] [Related]
26. Synchronous dual primary ovarian and endometrial carcinomas.
Pearl ML; Johnston CM; Frank TS; Roberts JA
Int J Gynaecol Obstet; 1993 Dec; 43(3):305-12. PubMed ID: 7907042
[TBL] [Abstract][Full Text] [Related]
27. CTNNB1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report.
Zhong L; Jiang W; RutieYin ; Liu H; Song L
BMC Med Genomics; 2023 Jun; 16(1):137. PubMed ID: 37328769
[TBL] [Abstract][Full Text] [Related]
28. Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach.
Wu RC; Veras E; Lin J; Gerry E; Bahadirli-Talbott A; Baras A; Ayhan A; Shih IM; Wang TL
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162652
[TBL] [Abstract][Full Text] [Related]
29. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
30. Synchronous squamous cell carcinoma of the endometrium and endometrioid adenocarcinoma of the ovary.
Grigoriadis C; Androutsopoulos G; Zygouris D; Arnogiannaki N; Terzakis E
Eur J Gynaecol Oncol; 2012; 33(6):666-8. PubMed ID: 23327069
[TBL] [Abstract][Full Text] [Related]
31. Does synchronous endometrioid endometrial cancer have any prognostic effect on Stage I endometrioid ovarian cancer?
Narin MA; Karalok A; Basaran D; Ureyen I; Turkmen O; Turan T; Tulunay G
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():113-6. PubMed ID: 27017531
[TBL] [Abstract][Full Text] [Related]
32. Synchronous ovarian and endometrial carcinoma: a strong link to endometriosis?
Kondi-Pafiti A; Grapsa D; Liapis A; Papadias K; Kairi-Vassilatou E; Hasiakos D
Eur J Gynaecol Oncol; 2008; 29(3):256-9. PubMed ID: 18592790
[TBL] [Abstract][Full Text] [Related]
33. Synchronous tumours of the female reproductive tract.
Gilks CB; Kommoss F
Pathology; 2018 Feb; 50(2):214-221. PubMed ID: 29249564
[TBL] [Abstract][Full Text] [Related]
34. Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers.
Kim SR; Tone A; Kim R; Cesari M; Clarke B; Eiriksson L; Hart T; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE
Int J Gynecol Cancer; 2020 Dec; 30(12):1951-1958. PubMed ID: 33082239
[TBL] [Abstract][Full Text] [Related]
35. Correspondence re: W.M. Lin et al., loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin. Cancer Res., 4: 2577-2583, 1998.
Matias-Guiu X; Bussaglia E; Catasus L; Lagarda H; Gras E; Machin P; Prat J
Clin Cancer Res; 2000 Apr; 6(4):1598-600. PubMed ID: 10778994
[No Abstract] [Full Text] [Related]
36. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
37. DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
Hsu Lin L; Allison DHR; Turashvili G; Vasudevaraja V; Tran I; Serrano J; Weigelt B; Ladanyi M; Abu-Rustum NR; Snuderl M; Chiang S
Mod Pathol; 2023 Nov; 36(11):100321. PubMed ID: 37652400
[TBL] [Abstract][Full Text] [Related]
38. Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
Manning-Geist BL; Rios-Doria E; Liu YL; Ellenson LH; Zhou QC; Iasonos A; Leitao MM; Abu-Rustum NR; Weigelt B; Mueller JJ
Int J Gynecol Cancer; 2024 May; 34(5):697-704. PubMed ID: 38508587
[TBL] [Abstract][Full Text] [Related]
39. Synchronous primary ovarian and endometrial cancer with a fair prognosis in a young woman.
Yang YH; Chen RJ; Lin MC; Cheng SP; Chang TC
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):97-100. PubMed ID: 20466303
[No Abstract] [Full Text] [Related]
40. Synchronous breast invasive ductal carcinoma and endometrial endometrioid adenocarcinoma: case report.
Yeh CC; Wang PH; Lai CR; Yen MS; Chao KC
J Obstet Gynaecol Res; 2011 Sep; 37(9):1246-9. PubMed ID: 21518130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
